Figure 1From: Modulating immunometabolism of tumor specific CD8 T cells to enhance T cell based therapy for cancer Degree of autoimmune-induced vitiligo 300 days after adoptive transfer of low TMRM (left) and high-TMRM (right) CD8+ T cells Back to article page